BRWA
BTCY

B. Riley Wealth Advisors’s Biotricity, Inc. Common Stock BTCY Stock Holding History

B. Riley Wealth Advisors’s Portfolio BTCY Stock Details BTCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,821
Closed -$9K – 1609
2022
Q3 		$9K Hold
1,821
– – ﹤0.01% 1438
2022
Q2 		$20K Hold
1,821
– – ﹤0.01% 1204
2022
Q1 		$25K Hold
1,821
– – ﹤0.01% 1361
2021
Q4 		$44K Hold
1,821
– – ﹤0.01% 1381
2021
Q3 		$33K Buy
+1,821
New +$34.2K ﹤0.01% 1384

Other funds holding BTCY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
AWM
AE Wealth Management Topeka, Kansas $18.5B AUM 19.51% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SWMP
Signature Wealth Management Partners Montvale, New Jersey $214M AUM 27.04% 1-Year Est. Return

B. Riley Wealth Advisors's BTCY Position: Q4 2022 in Review

B. Riley Wealth Advisors sold out of Biotricity, Inc. Common Stock (BTCY) in Q4 2022, closing a stake of 1,821 shares — an estimated $9K sold.

B. Riley Wealth Advisors first reported a position in BTCY in Q3 2021 and held it in 5 quarters. The position peaked at $44K in Q4 2021. 29 funds tracked by Wall St. Rank hold BTCY as of Q4 2022.

  • B. Riley Wealth Advisors reported no remaining Biotricity, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • B. Riley Wealth Advisors sold 1,821 Biotricity, Inc. Common Stock shares in Q4 2022, an estimated $9K.
  • B. Riley Wealth Advisors first reported a position in Biotricity, Inc. Common Stock in Q3 2021 and held it in 5 quarters.
  • B. Riley Wealth Advisors's Biotricity, Inc. Common Stock position peaked at $44K in Q4 2021.
  • 29 funds tracked by Wall St. Rank held Biotricity, Inc. Common Stock as of Q4 2022.

Based on B. Riley Wealth Advisors's 13F filing for Q4 2022, filed 21 Feb 2023.